About CDI Labs
CDI Labs is a company based in Mayaguez (United States) founded in 2001 by Ignacio Pino, Heng Zhu, Seth Blackshaw, and Jef Boeke. CDI Labs has raised $2.1 million across 6 funding rounds from investors including HHS and Broadoak Capital Partners. CDI Labs offers products and services including HuProt Microarray, VirScan Services, HuScan Services, and MouseScan Services. CDI Labs operates in a competitive market with competitors including Adimab, Aphios, QuaDRAD, OmniAb and AbCheck, among others.
- Headquarter Mayaguez, United States
- Founders Ignacio Pino, Heng Zhu, Seth Blackshaw, Jef Boeke
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cdi Laboratories, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.1 M (USD)
in 6 rounds
-
Latest Funding Round
Not available
-
Investors
HHS
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CDI Labs
CDI Labs offers a comprehensive portfolio of products and services, including HuProt Microarray, VirScan Services, HuScan Services, and MouseScan Services.
Microarray for analyzing over 21,000 human proteins in research
PhIP-Seq service for detecting antibodies against viral sequences
PhIP-Seq for profiling antibodies against human proteins
Service for detecting antibodies in murine proteins
People of CDI Labs
Unlock access to complete
Funding Insights of CDI Labs
CDI Labs has successfully raised a total of $2.1M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CDI Labs
CDI Labs has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Broadoak Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment banking services are offered in the United States.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for CDI Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CDI Labs
Investment portfolio details for CDI Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CDI Labs
Detailed financials for CDI Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cdi Labs Comparisons
Peer comparison for CDI Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CDI Labs
CDI Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adimab, Aphios, QuaDRAD, OmniAb and AbCheck, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibodies are discovered and optimized for autoimmune and infectious diseases.
|
|
| Locked | Locked | Locked |
Therapeutics for cancer and infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Antibody drug discovery platform
|
|
| Locked | Locked | Locked |
Transgenic animal platforms are developed for human therapeutic antibody production.
|
|
| Locked | Locked | Locked |
Developer of human therapeutic antibodies
|
Detailed competitors of CDI Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cdi Labs
Complete news archive for CDI Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CDI Labs
CDI Labs was founded in 2001 and raised its 1st funding round 9 years after it was founded.
CDI Labs is headquartered in Mayaguez, United States. It is registered at Mayaguez, Puerto Rico, United States.
Barney E Saunders is the current CEO of CDI Labs.
CDI Labs is a funded company, having raised a total of $2.1M across 6 funding rounds to date.
Founded in 2001 and based in Mayaguez, Puerto Rico, CDI Labs operates in the biotechnology sector. Products and services focused on autoantibody detection and profiling are developed and supplied. The HuProt array, featuring unique human proteins, isoform variants, and fragments, is utilized for human autoantibody seromics discovery, protein-protein interaction studies, target identification of unknown binders, and antibody specificity assessments. Operations support research in immunology and related fields.
CDI Labs offers HuProt Microarray, VirScan Services, HuScan Services, and MouseScan Services.
CDI Labs has 2 investors. Key investors include HHS, and Broadoak Capital Partners.